Novel 3D bioprinted liver tissue model reconstructs key aspects seen during drug-induced liver injury

Written by 3DMedNet

New 3D bioprinted human liver tissue – ExViveâ„¢ Human Liver Tissue from Organovo Holdings, Inc. (CA, USA) – shows promise in effectively modeling drug-induced liver injury. Organovo Holdings, Inc. (CA, USA) has recently collaborated with The Institute for Drug Safety Sciences and the University of North Carolina at Chapel Hill (both NC, USA) to demonstrate the advantages of using their ExViveâ„¢ Human Liver Tissue model over other in vitro cellular and animal models, to better understand the progression of liver injury. The findings, recently published in Toxicological Sciences, report on how the 3D printed human liver tissue can outline the...

To view the full article, please register now for access

It's completely free